This inventor holds 1 USPTO granted patent. Top assignee: Akzo Nobel N.v.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Cornelis Maria Tromp: Innovator in Antithrombotic Compounds
Introduction
Cornelis Maria Tromp is a notable inventor based in Ravenstein, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antithrombotic compounds. His innovative work has the potential to impact the treatment and prevention of thrombin-related diseases.
Latest Patents
Cornelis Maria Tromp holds a patent for an antithrombotic compound. The patent describes compounds of a specific formula, where R can be either SO or CH. The invention features a flexible spacer consisting of 13-25 atoms, with positively charged counterions compensating the charge of the pentasaccharide residue. The total number of sulfate groups in the pentasaccharide residue is either 4, 5, or 6, or it may include a pharmaceutically acceptable salt, prodrug, or solvate. These compounds exhibit antithrombotic activity, making them valuable for treating or preventing thrombin-related diseases.
Career Highlights
Cornelis Maria Tromp is associated with Akzo Nobel N.V., a leading company in the field of chemicals and coatings. His work at the company has allowed him to focus on innovative solutions in pharmaceuticals, particularly in the area of antithrombotic therapies.
Collaborations
Cornelis has collaborated with notable colleagues, including Constant Adriaan Anton Van Boeckel and Tamara Theodora Maria Geertsen. These collaborations have contributed to the advancement of research and development in their respective fields.
Conclusion
Cornelis Maria Tromp is a distinguished inventor whose work in antithrombotic compounds showcases his commitment to advancing medical science. His contributions have the potential to significantly improve treatment options for thrombin-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
